BioCentury | Mar 14, 2017
Company News

Blue Shield establishes practices for CED

Blue Shield of California has established new procedures for coverage with evidence development (CED), and looks to be among the first private commercial payers to adopt such a practice. CED has traditionally been used by...
BioCentury | Mar 9, 2015
Strategy

Prepping for PCSK9s

...NYSE:ABBV), Abbott Park, Ill. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Blue Shield of California...
...it has reached exclusive deals "with a number of different regional" payers and PBMs, including Blue Shield of California...
BioCentury | Jan 31, 2015
Company News

AbbVie forecasts $3B run rate for Viekira Pak

...exclusive deals "with a number of different more regional" payers and PBMs, including Blue Shield of California . Blue Shield of California...
BioCentury | Dec 15, 2014
Company News

Veracyte sales and marketing update

...Veracyte said Blue Shield of California issued positive coverage decisions for Afirma Gene Expression Classifier . Afirma is a...
...aspirate (FNA) samples to aid in identifying benign tumors from inconclusive thyroid nodules. Veracyte said Blue Shield of California...
BioCentury | Mar 17, 2014
Clinical News

Sovaldi sofosbuvir regulatory update

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Mar 17, 2014
Clinical News

Olysio simeprevir regulatory update

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Mar 11, 2014
Politics & Policy

Group says HCV drugs effective, but lack value

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Aug 5, 2013
Company News

CombiMatrix, Blue Shield of California sales and marketing update

...CombiMatrix entered into a contract with health insurer Blue Shield of California to cover CombiMatrix's entire portfolio of testing...
...abnormality, under an expanded 2012 deal (see BioCentury, July 15). CombiMatrix Corp. (NASDAQ:CBMX), Mukilteo, Wash. Blue Shield of California...
BioCentury | Oct 29, 2012
Clinical News

MaterniT21 PLUS laboratory-developed test regulatory update

...18 and 21 in average-risk women. CTAF is a public service forum sponsored by the Blue Shield of California...
BioCentury | Oct 10, 2011
Company News

Roche cancer news

Blue Shield of California said it will no longer cover Avastin bevacizumab for metastatic breast cancer, effective Oct. 17. The insurance provider, which did not provide a reason for the change, said exceptions may be...
Items per page:
1 - 10 of 20
BioCentury | Mar 14, 2017
Company News

Blue Shield establishes practices for CED

Blue Shield of California has established new procedures for coverage with evidence development (CED), and looks to be among the first private commercial payers to adopt such a practice. CED has traditionally been used by...
BioCentury | Mar 9, 2015
Strategy

Prepping for PCSK9s

...NYSE:ABBV), Abbott Park, Ill. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Blue Shield of California...
...it has reached exclusive deals "with a number of different regional" payers and PBMs, including Blue Shield of California...
BioCentury | Jan 31, 2015
Company News

AbbVie forecasts $3B run rate for Viekira Pak

...exclusive deals "with a number of different more regional" payers and PBMs, including Blue Shield of California . Blue Shield of California...
BioCentury | Dec 15, 2014
Company News

Veracyte sales and marketing update

...Veracyte said Blue Shield of California issued positive coverage decisions for Afirma Gene Expression Classifier . Afirma is a...
...aspirate (FNA) samples to aid in identifying benign tumors from inconclusive thyroid nodules. Veracyte said Blue Shield of California...
BioCentury | Mar 17, 2014
Clinical News

Sovaldi sofosbuvir regulatory update

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Mar 17, 2014
Clinical News

Olysio simeprevir regulatory update

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Mar 11, 2014
Politics & Policy

Group says HCV drugs effective, but lack value

...to improve the quality and value of healthcare. CTAF was funded and managed by the Blue Shield of California...
BioCentury | Aug 5, 2013
Company News

CombiMatrix, Blue Shield of California sales and marketing update

...CombiMatrix entered into a contract with health insurer Blue Shield of California to cover CombiMatrix's entire portfolio of testing...
...abnormality, under an expanded 2012 deal (see BioCentury, July 15). CombiMatrix Corp. (NASDAQ:CBMX), Mukilteo, Wash. Blue Shield of California...
BioCentury | Oct 29, 2012
Clinical News

MaterniT21 PLUS laboratory-developed test regulatory update

...18 and 21 in average-risk women. CTAF is a public service forum sponsored by the Blue Shield of California...
BioCentury | Oct 10, 2011
Company News

Roche cancer news

Blue Shield of California said it will no longer cover Avastin bevacizumab for metastatic breast cancer, effective Oct. 17. The insurance provider, which did not provide a reason for the change, said exceptions may be...
Items per page:
1 - 10 of 20